{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T13:31:05Z","timestamp":1776346265455,"version":"3.51.2"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Fluoresc"],"DOI":"10.1007\/s10895-025-04675-3","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:21:40Z","timestamp":1767705700000},"page":"2025-2034","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Smart Fluorescence-Responsive Polymer Hybrid Nanoparticles for Ferroptosis-Associated Therapy and Pathological Ion Detection in OSCC Cells"],"prefix":"10.1007","volume":"36","author":[{"given":"Shujuan","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leidi","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,6]]},"reference":[{"key":"4675_CR1","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1186\/s12903-024-04395-3","volume":"24","author":"C Mao","year":"2024","unstructured":"Mao C, Gong L, Kang W (2024) Effect and mechanism of resveratrol on ferroptosis mediated by p53\/SLC7A11 in oral squamous cell carcinoma. BMC Oral Health 24:773","journal-title":"BMC Oral Health"},{"key":"4675_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2022.153778","volume":"231","author":"K Sun","year":"2022","unstructured":"Sun K, Ren W, Li S, Zheng J, Huang Y, Zhi K, Gao L (2022) MiR-34c-3p upregulates erastin-induced ferroptosis to inhibit proliferation in oral squamous cell carcinomas by targeting SLC7A11. Pathol Res Pract 231:153778","journal-title":"Pathol Res Pract"},{"key":"4675_CR3","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1002\/cam4.1110","volume":"6","author":"Y Wu","year":"2017","unstructured":"Wu Y, Sun X, Song B, Qiu X, Zhao J (2017) MiR-375\/SLC7A11 axis regulates oral squamous cell carcinoma proliferation and invasion. Cancer Med 6:1686\u20131697","journal-title":"Cancer Med"},{"key":"4675_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.archoralbio.2023.105762","volume":"154","author":"Z Liu","year":"2023","unstructured":"Liu Z, Wang X, Liu L, Guan M, Jiang H, An D, Li H (2023) Long non-coding RNA SLC7A11 antisense RNA1 promotes oral squamous cell carcinoma progression by regulating ubiquitination of K-homology type splicing regulatory protein. Arch Oral Biol 154:105762","journal-title":"Arch Oral Biol"},{"key":"4675_CR5","doi-asserted-by":"publisher","first-page":"1432520","DOI":"10.3389\/fphar.2024.1432520","volume":"15","author":"K Sun","year":"2024","unstructured":"Sun K, Gao L, Li S, Zheng J, Zhu Z, Zhi K, Ren W (2024) Circ-CDK8 regulates SLC7A11-mediated ferroptosis by inhibiting miR-615-5p to promote progression in oral squamous cell carcinomas. Front Pharmacol 15:1432520","journal-title":"Front Pharmacol"},{"key":"4675_CR6","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1021\/acs.bioconjchem.4c00462","volume":"35","author":"S Wang","year":"2024","unstructured":"Wang S, Bai X, Wang X, Wang J, Tao W, Gao Y, Ning J, Hao J, Gao M (2024) Metal polyphenol nanoparticle-based chemo\/ferroptosis synergistic therapy for the treatment of oral squamous cell carcinoma. Bioconjug Chem 35:1835\u20131842","journal-title":"Bioconjug Chem"},{"key":"4675_CR7","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1111\/odi.14085","volume":"29","author":"L Cui","year":"2023","unstructured":"Cui L, Huang C, Zhou D (2023) Overexpression of circCDR1as drives oral squamous cell carcinoma progression. Oral Dis 29:957\u2013967","journal-title":"Oral Dis"},{"key":"4675_CR8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41368-018-0037-7","volume":"10","author":"S Yost","year":"2018","unstructured":"Yost S, Stashenko P, Choi Y, Kukuruzinska M, Genco CA, Salama A, Weinberg EO, Kramer CD, Frias-Lopez J (2018) Increased virulence of the oral microbiome in oral squamous cell carcinoma revealed by metatranscriptome analyses. Int J Oral Sci 10:32","journal-title":"Int J Oral Sci"},{"key":"4675_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.137565","volume":"283","author":"L Xia","year":"2024","unstructured":"Xia L, Wang H, Du G, Cheng X, Zhang R, Yu H, Cheng M, Chen Y, Qin S, Leng W (2024) Receptor accessory protein 6, a novel ferroptosis suppressor, drives oral squamous cell carcinoma by maintaining endoplasmic reticulum hemostasis. Int J Biol Macromol 283:137565","journal-title":"Int J Biol Macromol"},{"key":"4675_CR10","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.canlet.2021.05.001","volume":"515","author":"B Ren","year":"2021","unstructured":"Ren B, Kwah MXY, Liu C, Ma Z, Shanmugam MK, Ding L, Xiang X, Ho PCL, Wang L, Ong PS, Goh BC (2021) Resveratrol for cancer therapy: challenges and future perspectives. Cancer Lett 515:63\u201372","journal-title":"Cancer Lett"},{"key":"4675_CR11","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.3390\/ijms18122589","volume":"18","author":"JH Ko","year":"2017","unstructured":"Ko JH, Sethi G, Um JY, Shanmugam MK, Arfuso F, Kumar AP, Bishayee A, Ahn KS (2017) The role of resveratrol in cancer therapy. Int J Mol Sci 18:2589","journal-title":"Int J Mol Sci"},{"key":"4675_CR12","doi-asserted-by":"publisher","first-page":"12422","DOI":"10.1080\/10408398.2022.2101428","volume":"63","author":"SX Wu","year":"2023","unstructured":"Wu SX, Xiong RG, Huang SY, Zhou DD, Saimaiti A, Zhao CN, Shang A, Zhang YJ, Gan RY, Li HB (2023) Effects and mechanisms of resveratrol for prevention and management of cancers: an updated review. Crit Rev Food Sci Nutr 63:12422\u201312440","journal-title":"Crit Rev Food Sci Nutr"},{"key":"4675_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15102758","volume":"15","author":"B Song","year":"2023","unstructured":"Song B, Wang W, Tang X, Goh RM, Thuya WL, Ho PC, Chen L, Wang L (2023) Inhibitory potential of resveratrol in cancer metastasis: from biology to therapy. Cancers (Basel) 15:2758","journal-title":"Cancers (Basel)"},{"key":"4675_CR14","doi-asserted-by":"publisher","first-page":"4709","DOI":"10.1021\/acs.jafc.9b01667","volume":"67","author":"M Wang","year":"2019","unstructured":"Wang M, Jiang S, Yu F, Zhou L, Wang K (2019) Noncoding RNAs as molecular targets of resveratrol underlying its anticancer effects. J Agric Food Chem 67:4709\u20134719","journal-title":"J Agric Food Chem"},{"key":"4675_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-93112-3","volume":"15","author":"SK Ezzat","year":"2025","unstructured":"Ezzat SK, Anter HM, Habotta OA, Esmaeil DM, Farag DA, Aman RM (2025) Poly lactic-co-glycolic acid enhances the efficacy of the phytomedicine chrysin against cisplatin induced toxicity in submandibular salivary glands. Sci Rep 15:10262","journal-title":"Sci Rep"},{"key":"4675_CR16","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1039\/D4NR05026F","volume":"17","author":"G Perini","year":"2025","unstructured":"Perini G, Minopoli A, Zambrano D, Cui L, Ferrara V, Perfili C, Artemi G, De Spirito M, Palmieri V, Rosenkranz A, Papi M (2025) Impact of different 2D materials on the efficacy of photothermal and photodynamic therapy in 3D-bioprinted breast cancer. Nanoscale 17:3221\u20133235","journal-title":"Nanoscale"},{"key":"4675_CR17","doi-asserted-by":"publisher","first-page":"102809","DOI":"10.1016\/j.nantod.2025.102809","volume":"64","author":"J Cheng","year":"2025","unstructured":"Cheng J, Li J, Wu J, Kang W, Feng K, You Y, Wan C, Zheng Y, Yan L, Liu R, Zhao F, Li Y (2025) A novel hypocrellin B derivative for photodynamic therapy-driven cancer immunotherapy via triggering immunogenic cell death. Nano Today 64:102809","journal-title":"Nano Today"},{"key":"4675_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ma17225480","volume":"17","author":"F Villapiano","year":"2024","unstructured":"Villapiano F, Piccioni M, D\u2019aria F, Crispi S, Rassu G, Giunchedi P, Gavini E, Giancola C, Serri C, Biondi M, Mayol L (2024) Silibinin-loaded amphiphilic PLGA\u2013poloxamer nanoparticles: physicochemical characterization, release kinetics, and bioactivity evaluation in lung cancer cells. Materials 17:5480","journal-title":"Materials"},{"key":"4675_CR19","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adr4762","volume":"10","author":"S Koshrovski-Michael","year":"2024","unstructured":"Koshrovski-Michael S, Ajamil DR, Dey P, Kleiner R, Tevet S, Epshtein Y, Green BM, Khoury R, Pozzi S, Shenbach-Koltin G, Yeini E, Woythe L, Blau R, Scomparin A, Barshack I, Florindo HF, Lazar S, Albertazzi L, Amir RJ, Satchi-Fainaro R (2024) Two-in-one nanoparticle platform induces a strong therapeutic effect of targeted therapies in P-selectin\u2013expressing cancers. Sci Adv 10:eadr4762","journal-title":"Sci Adv"},{"key":"4675_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125483","volume":"674","author":"S Shrestha","year":"2025","unstructured":"Shrestha S, Giri A, Shrestha P, Kweon S, Hong IS, Kwon TK, Kang JS, Jeong JH, Kim HR, Yook S (2025) CD44-targeted nanoparticles for remodeling the tumor microenvironment in a 3D macrophage-embedded ovarian cancer model with stem cell-like features. Int J Pharm 674:125483","journal-title":"Int J Pharm"},{"key":"4675_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2023.106425","volume":"185","author":"Y Ma","year":"2023","unstructured":"Ma Y, Cong Z, Gao P, Wang Y (2023) Nanosuspensions technology as a master key for nature products drug delivery and in vivo fate. Eur J Pharm Sci 185:106425","journal-title":"Eur J Pharm Sci"},{"key":"4675_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.indcrop.2024.118815","volume":"218","author":"MK Shukla","year":"2024","unstructured":"Shukla MK, Kaushik H, Tiwari H, Behera C, Tonk RK, Husain A, Singh J, Kesari KK, Kumar D (2024) Development and characterization of Myrica esculenta plant extract-based albumin nanoparticles for anticancer activity. Ind Crops Prod 218:118815","journal-title":"Ind Crops Prod"},{"key":"4675_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11122351","volume":"11","author":"CS Wang","year":"2022","unstructured":"Wang CS, Luo SD, Jia S, Wu W, Chang SF, Feng SW, Yang CH, Lin JH, Wee Y (2022) Balance of macrophage activation by a complex coacervate-based adhesive drug carrier facilitates diabetic wound healing. Antioxidants 11:2351","journal-title":"Antioxidants"},{"key":"4675_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.105113","volume":"90","author":"OF Comert","year":"2023","unstructured":"Comert OF, Kalin S, Onder A, Ozay H, Ozay O (2023) Assessment of release and anticancer effect of innovative pH-responsive and antioxidant-biodegradable hydrogel by using Parthenocissus quinquefolia L. extract as a crosslinker. J Drug Deliv Sci Technol 90:105113","journal-title":"J Drug Deliv Sci Technol"},{"key":"4675_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s11671-024-04164-9","volume":"20","author":"N Suresh","year":"2025","unstructured":"Suresh N, Thomas NG, Mauramo M, Waltimo T, Sorsa T, Anil S (2025) Phytonanoparticles as novel drug carriers for enhanced osteogenesis and osseointegration. Discover Nano 20:11","journal-title":"Discover Nano"}],"container-title":["Journal of Fluorescence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10895-025-04675-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10895-025-04675-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10895-025-04675-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T12:38:16Z","timestamp":1776343096000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10895-025-04675-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,6]]},"references-count":25,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["4675"],"URL":"https:\/\/doi.org\/10.1007\/s10895-025-04675-3","relation":{},"ISSN":["1573-4994"],"issn-type":[{"value":"1573-4994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,6]]},"assertion":[{"value":"1 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}